Penelope Gray

发表

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.

M. Lehtinen, M. Pawlita, T. Waterboer, 2021, The Lancet. Infectious diseases.

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women

M. Lehtinen, J. Dillner, D. Apter, 2019, International journal of cancer.

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

M. Lehtinen, J. Dillner, D. Apter, 2021, BMJ Open.

In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers

M. Lehtinen, Simopekka Vänskä, K. Louvanto, 2022, Expert review of vaccines.

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses

M. Lehtinen, J. Dillner, V. Pimenoff, 2022, The Journal of infectious diseases.

Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised HPV vaccination trial with moderate coverage

M. Lehtinen, J. Dillner, H. Surcel, 2020, International journal of cancer.

Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)

M. Lehtinen, J. Dillner, Simopekka Vänskä, 2019, International journal of cancer.

Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II)

M. Lehtinen, J. Dillner, G. Garnett, 2018, International journal of cancer.

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial

M. Lehtinen, J. Dillner, H. Surcel, 2021, PLoS medicine.

Scientific approaches toward improving cervical cancer elimination strategies.

J. Dillner, L. Bruni, Simopekka Vänskä, 2024, International journal of cancer.

Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic

J. Dillner, Penelope Gray, M. Elfström, 2023, eLife.

Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts.

V. Pimenoff, Tiina Eriksson, C. Lagheden, 2023, Cell host & microbe.

HPV16 E6‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study

M. Lehtinen, T. Waterboer, H. Surcel, 2023, International journal of cancer.

Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.

B. Nedjai, V. Pimenoff, D. Ścibior-Bentkowska, 2024, International journal of cancer.